From 20+ VC and partner meetings to global media buzz — Signaling makes its mark on the world stage
Vespexx (Co-CEO Scarlett Joowon Jung), a subsidiary of in vitro diagnostics specialist Sugentech, garnered significant global attention at CES 2025 with its receipt of the AI Wellness 111 Innovation Award. Its global couples app Signaling — which reached 400,000 cumulative downloads and 180,000 monthly active users in just 10 months — validated the platform's innovative potential by creating an entirely new market category: relational healthcare.
Far more than a calendar app, Signaling is an AI-powered platform that helps couples build healthier, more sustainable relationships by sharing health data, schedules, and finances together. CES 2025 served as a key milestone in accelerating Vespexx's push into global markets, including North America and East Asia.
At CES 2025, Vespexx generated considerable buzz on the exhibition floor through interviews with global media and organizations including BBC, CTA, and AI Wellness, as well as a featured interview with a former Miss America reporter, Malary Stone. The company also secured more than 20 follow-up meetings with venture capital firms and potential partners, marking a highly successful showing.
The Vespexx booth drew steady crowds throughout the event, with Co-CEO Scarlett Joowon Jung personally introducing Signaling's core features and AI-driven health insight technology to attendees. Signaling integrates schedule management, health tracking, and lifestyle sharing into a single platform — enabling meaningful couple interaction and providing an innovative solution for managing health and daily habits together, with particular emphasis on precise analysis of female hormone data.
Vespexx is accelerating its global strategy off the back of CES 2025. The company has launched a globally available premium service, targeting 1 million global users and 500,000 monthly active users within the year. Localization efforts are underway with multilingual support and region-specific features, with Japan and North America as primary markets, while the company continues to expand into the broader healthcare and femtech sectors. By establishing a new relational healthcare ecosystem, Vespexx is delivering enhanced wellness experiences through both social and physical couple interactions.
Co-CEO Scarlett Joowon Jung stated: "We are fully prepared to support couples' health and relationships through AI and digital healthcare technology in increasingly sophisticated ways. Signaling will lead the global wellness market as an innovative platform encompassing couples' daily life, health, and financial management."
Through CES 2025, Vespexx is solidifying its position in the global wellness market and building the foundation for couples to maintain healthier, smarter relationships. The industry is watching closely as Vespexx positions itself as a dominant force shaping the future of the wellness ecosystem.
Original Article By:
Aving Global News Network
The content has been translated and edited from the original article.
